Dysregulation of interferon regulatory genes reinforces the concept of chronic immune response in myelodysplastic syndrome pathogenesis

Hematol Oncol. 2019 Oct;37(4):523-526. doi: 10.1002/hon.2608. Epub 2019 Jul 15.

Juliana Cordeiro de Sousa¹, Mayumi da Nóbrega Ito^{1

2}, Marilia Braga Costa^{1

2}, Izabelle Rocha Farias^{1

2}, Daniela de Paula Borges^{1

2}, Roberta Taiane de Oliveira^{1

2}, Kiyoshi Ferreira Fukutani³, Carolina Hassibe Thomé⁴, Camila Maria da Silva Martinelli⁵, Fabio Myajima^{2

6}, Daniel Onofre Vidal⁵, Silvia Maria Meira Magalhães¹, Lorena Lobo Figueiredo-Pontes⁴, Ronald Feitosa Pinheiro^{1

2}

¹ Cytogenomic Laboratory, Postgraduate Medical Science, University Federal of Ceará, Fortaleza, Brazil.
² Center for Drug Research and Development, Federal University of Ceará (NPDM, UFC), Fortaleza, Brazil.
³ Department of Biochemistry, Immunology, and Cell Biology, the Center for Research in Inflammatory Diseases, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
⁴ Hematology Division, Ribeirao Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
⁵ Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil.
⁶ Fundação Oswaldo Cruz, Ceará Fiocruz, Brazil.

No abstract available

Publication types